Tuesday, December 18th, 2012 at
A recently concluded research published in the journal SLEEP attempted to determine the neurocognitive effects of continuous positive airway pressure (CPAP) therapy on patients with obstructive sleep apnea (OSA).
The Apnea Positive Pressure Long-term Efficacy Study was a 6-month, randomized, double-blind, 2-arm, sham-controlled, multicenter trial conducted at 5 U.S. university, hospital, or private practices. Of 1,516 participants enrolled, 1,105 were randomized, and 1,098 participants diagnosed with OSA contributed to the analysis of the primary outcome measures. Read the rest of this entry
Monday, December 17th, 2012 at
A night sweat is a “hot flash” that occurs in the night, often while one is sleeping. A hot flash, also called a hot flush, is a sudden unexpected feeling of warmth and often a breakout of sweating in the upper half of the body. These flashes are experienced by 80% of women around the time of menopause, and men can also have them due to a lessening of testosterone.
At night time while a woman sleeps, her body temperature rises steeply just prior to a hot flash, causing her to wake up. The National Sleep Foundation writes that as many as 61% of post-menopausal women report having symptoms of insomnia and less satisfying sleep, due in part due to hot flashes interrupting their sleep with frequent awakenings. Read the rest of this entry
Monday, December 17th, 2012 at
Females with obstructive sleep apnea (OSA) show different psychological and physiological symptoms from males, which may be associated with sex-related variations in neural injury occurring with the disorder. To determine whether male- or female-specific brain injury is present in OSA, we assessed influences of sex on white matter changes in the condition.
80 subjects total, with newly diagnosed, untreated OSA groups of 10 female (age mean ± SE: 52.6 ± 2.4 years, AHI 22.5 ± 4.1 events/h) and 20 male (age 48.9 ± 1.7, AHI 25.5 ± 2.9) patients, and 20 female (age 50.3 ± 1.7) and 30 male (age 49.2 ± 1.4) healthy control subjects. Read the rest of this entry
Sunday, December 16th, 2012 at
A research concluded recently has revealed its findings that those who are suffering from obstructive sleep apnea (OSA) may control the sleep issue while traveling to higher altitudes if they can combine auto-adjusted continuous positive airway pressure (autoCPAP) with acetazolamide.
“Our study provides important information for patients with OSA planning a stay at altitude because they can continue using their CPAP in auto-adjusting mode during altitude travel and enhance this treatment with acetazolamide if they want to spend less time awake at night, to achieve a higher arterial oxygen saturation and an optimal control of sleep apnea,” said Konrad Bloch, from University Hospital of Zurich in Switzerland. Read the rest of this entry
Saturday, December 15th, 2012 at
A recently concluded research evaluation of a patient revealed that even perfect control on blood glucose level does not help, they found.
The patient, with a HBA1C of 9.3 per cent, was evaluated for a 24-hour period for three things — blood glucose levels during sleep, heart rhythm and sleep hygiene. He had three to four episodes of asymptomatic hypoglycaemia (low blood glucose). Though he did not exhibit sleep disturbances, if hypoglycaemia remained untreated, it might become fatal.
A patient with hypoglycaemia, when awake, would typically experience sweating and tremors and eating a chocolate would result in a rise in glucose levels. But, these symptoms are absent while a patient is sleeping. “Hypoglycaemia has been recognised as a potential cause of death ever since the introduction of insulin therapy. Read the rest of this entry
Thursday, November 22nd, 2012 at
Children with Prader-Willi syndrome are likely to get relief from sleep disorders after undergoing an adenotonsillectomy.
A recently concluded research study from Nationwide Children’s Hospital published in the November print issue of the Archives of Otolaryngology-Head and Neck Surgery revealed the outcome.
“Patients with Prader-Willi syndrome are at risk for sleep disordered breathing as growth hormone commonly used to treat their condition can cause the tonsils and adenoids to enlarge,” said the study’s lead author Kris Jatana, MD, FAAP, with Otolaryngology Head & Neck Surgery at Nationwide Children’s. Read the rest of this entry
Monday, November 19th, 2012 at
Obstructive Sleep Apnea (OSA) has been associated with increased cancer mortality, but whether it is also associated with cancer incidence is unknown.
Researchers accomplished a detailed investigation whether OSA is associated with increased cancer incidence in a large clinical cohort.
Multicenter, clinical cohort study including consecutive patients investigated for suspected OSA between 2003-2007 in 7 Spanish teaching hospitals. Apnea-hypopnea index (AHI) and percent night-time with oxygen saturation <90% (TSat90) were used as surrogates of OSA severity, both as continuous variables and categorized by tertiles. Cox proportional hazards regression analyses were used to calculate hazard ratios (HR) and 95%CI for cancer incidence after adjusting for confounding variables. Read the rest of this entry
Saturday, November 17th, 2012 at
Obesity is a strong indicator in the development of sleep apnea, a serious sleep disorder. About 85 % of those with sleep apnea are obese, and it is more common in men over age 40. Sleep apnea is associated with health consequences such as an increased risk of heart disease, stroke, and diabetes. Treatment for sleep apnea can effectively improve concentration, energy, and overall quality of life and put an end to snoring.
Weight loss surgery at LAP-BAND VIP can effectively prevent, treat, or resolve sleep apnea and cause remission in up to 85 percent of patients.
Excess weight and sleep apnea are strongly correlated because obese people tend to have thicker tissue around the throat. This leads to tissue collapse in the airway, and sleep apnea is marked by disruptions in breathing which can last up to 60 seconds called apneas. During these apneas, a person will wake up to resume breathing, sometimes hundreds of times a night. Read the rest of this entry
Thursday, November 15th, 2012 at
Not everyone is lucky enough to enjoy the life’s simple pleasure, a good night’s sleep.
It is estimated that at least 40 million Americans suffer from chronic or long-term sleep disorders, and an additional 20 million experience occasional sleeping problems. Obstructive sleep apnea, insomnia, restless legs syndrome and narcolepsy are some of the most common sleep disorders.
A chronic and little-known sleep dysfunction, mostly observed in blind people, is non-24-hour sleep-wake disorder, also known as N24HSWD, which results in symptoms of insomnia and/or excessive sleepiness.
This debilitating circadian rhythm sleep disorder affects individuals who are unable to synchronize their internal body clock to the standard 24-hour light-dark cycle, and therefore they do not necessarily associate night with sleep, and day with being awake. The chronic sleep deprivation due to N24HSWD may lead to impairment in daily functioning, social interactions, school and work performance, and increases the risk for accidents. Read the rest of this entry
Wednesday, November 14th, 2012 at
SleepApneaDisorder/OKLAHOMA CITY/ Press Release/ Graymark Healthcare, Inc. the nation’s second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), announces an equity investment.
A newly formed entity, Oklahoma Health Partners (OHP), announced their intent to purchase 1,444,445 shares of common stock of Graymark Healthcare (GRMH) for $650,000 at $0.45 per share. The transaction is expected to close no later than November 14, 2013.
Oklahoma Health Partners is managed by Mr. Mike Horrell. Mr. Horrell is a significant investor in numerous health care related companies and health care real estate projects. Read the rest of this entry